Multicenter Trial of Hemodilution in Ischemic Stroke "SSS"

Completed

Phase 3 Results

Results

Three-month survival expressed as life table product was 0.84 in hemodilution and 0.88 in control patients. In survivors, neurologic score and activities of daily living performance during 3 months of follow-up were not improved by hemodilution.